cagrilintide news and semaglutide together drive record weight loss in global trial Cagrilintide 10mg - Leo Research
Description
Here is the honest state of the data: Obesity (Phase 2, randomized controlled trial): the landmark New England Journal of Medicine Phase 2 trial in obesity established both the once-weekly dosing and the escalation approach, and reported the largest average weight reductions seen for a once-weekly agent with the caveat that the reduction had not fully plateaued at 48 weeks
Lee, S., & Dong, H
In some cases, LH levels become frankly elevated
But now, more people are asking whether it could also help with chronic pain the kind that sticks around for months or years
